Arcutis Biotherapeutics (NASDAQ:ARQT) reported quarterly losses of $(1.14) per share. This is a 12.87 percent decrease over losses of $(1.01) per share from the same period last year.
Lawsuit Claims Netflix Series “13 Reasons Why” Caused Spike in Suicides, Could Limit Future Media Production
Netflix Inc. (NASDAQ: NFLX) is facing a lawsuit from thousands of parents who claim that the platform's hit series 13 Reasons Why led to increased child suicide rates immediately after it was released.
